All Resources

Delivering COVID-19 vaccines to 7.8 billion people was a daunting challenge that stretched supply chains past their limits. This white paper dives into vaccine distribution plans and what vaccine manufacturers, distributors and administrators can take away from this monumental time in both the industry and history. Learn how temperature indicators and monitoring solutions played an essential role in the administration of the COVID-19 vaccine.

Data loggers, data monitors and temperature indicators are three reliable solutions for determining what has occurred during shipping and handling of pharmaceuticals. Deciding which temperature monitoring solution will work best for your operation depends upon the product, its value, delivery method and stage in the supply chain. Discover which solution is right for you in our white paper.

Shipping medications directly from a pharmacy to a patient’s home is standard practice and maintaining proper temperature during shipment is crucial. Temperature fluctuations can cause medications to become less effective and cause harm to a patient’s health. Learn how adding a temperature indicator can help ensure the safety of customers, protect your reputation, and reduce time and costs.

With telemedicine, more medications and diagnostics are being shipped directly to patients’ homes and – for diagnostics, from a home to a lab. Discover how a freeze indicator can guarantee this precious cargo does not freeze during the process. A simple visual check alerts the recipient if the temperature has been unacceptably cold.

With millions of doses of the influenza vaccine being administered during the flu season, it's essential to make sure every vaccine is well protected. Discover how indicators can trigger only when product temperatures have exceeded maximums for a specific period of time. With at-a-glance ease, healthcare professionals can know instantly whether vaccines maintained proper temperatures during shipping adding confidence that vaccines have maintained their efficacy.

Among a variety of Hub vendors, what specific qualities distinguish differentiated support for drug manufacturers? To help answer this question, CareMetx conducted in-depth interviews and surveys with senior leadership at top manufacturers.

In a recent study, CareMetx engaged with senior leadership at leading biopharmaceutical manufacturers, aiming to evaluate the optimal ways in which Hub data can enhance manufacturer support. These findings can serve as a valuable guide for manufacturers seeking insights on optimizing their utilization of Hub data.

CareMetx, a Hub services company that provides high-touch support to drive therapy initiation and adherence, conducted research involving over 100 participants, using both qualitative and quantitative methods. The primary aim was to understand how therapy manufacturers envision the future of Hubs.

What the Changing Healthcare Landscape Demands of Future MA Professionals?

Throughout the specialty pharmacy industry, leaders are beginning to spend more time thinking about the overall patient experience, and how patients benefit from having quicker access to therapy. In this conversation, CareMetx Chief Patient Experience Officer Jessica Lens dives deeper into the patient experience- particularly in the early treatment phases, helping us understand patient behavior around initiating and taking medication, and how to impact that behavior. In short- we discuss a need to broaden the scope of what we currently call “adherence” to consider the reality that patient medication taking attitudes, beliefs, mindset, and behavior - starts long before the first dose.

Throughout the specialty pharmacy industry, leaders are beginning to spend more time thinking about the overall patient experience, and how patients benefit from having quicker access to therapy. In this conversation, CareMetx Chief Patient Experience Officer Jessica Lens dives deeper into the patient experience- particularly in the early treatment phases, helping us understand patient behavior around initiating and taking medication, and how to impact that behavior. In short- we discuss a need to broaden the scope of what we currently call “adherence” to consider the reality that patient medication taking attitudes, beliefs, mindset, and behavior - starts long before the first dose.

When choosing a 3PL whether for a new product launch in the near future or re re-evaluating your current situation, certain key considerations must be addressed before you make a final decision.

Sponsored by Dragos, the Ponemon Institute’s report on the State of Industrial Cybersecurity finds that cultural and technical differences between traditional IT best practices and what is possible in OT increases an organization’s risk for costly cyber incidents – and the average cost to detect, investigate, and remediate an event.

As operational technology (OT) cybersecurity becomes a top priority from boardrooms to the manufacturing floor, CISOs and their teams must implement proven strategies to protect the business. OT, however, has long been underrepresented, leading to communication challenges, a cultural gap with IT, and uncertainty about how to move forward.

The top criteria to consider when evaluating and choosing the right airfreight container that can efficiently protect pharma’s cold chain 

This whitepaper looks at SkyCell’s sustainability policies and our commitments to work together for a greener pharma supply chain.

Transitioning a rare disease HUB or NCP program to a rare-focused partner can yield major service quality improvements without program disruption.